U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Christopher J. Reading Sells 7,000 Shares

Share on StockTwits

U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Christopher J. Reading sold 7,000 shares of the firm’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $135.13, for a total transaction of $945,910.00. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Christopher J. Reading also recently made the following trade(s):

  • On Thursday, August 15th, Christopher J. Reading sold 601 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $135.39, for a total transaction of $81,369.39.
  • On Tuesday, May 21st, Christopher J. Reading sold 19,860 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $119.36, for a total transaction of $2,370,489.60.

Shares of NYSE USPH opened at $135.11 on Thursday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.88 and a current ratio of 1.88. The company has a market cap of $1.72 billion, a P/E ratio of 50.98, a P/E/G ratio of 3.74 and a beta of 1.13. The firm’s fifty day moving average is $128.52 and its two-hundred day moving average is $116.52. U.S. Physical Therapy, Inc. has a 52-week low of $98.69 and a 52-week high of $137.15.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, August 8th. The company reported $0.81 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.81. The company had revenue of $126.40 million for the quarter, compared to the consensus estimate of $124.86 million. U.S. Physical Therapy had a net margin of 6.22% and a return on equity of 19.19%. U.S. Physical Therapy’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.73 EPS. As a group, analysts forecast that U.S. Physical Therapy, Inc. will post 2.94 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Thursday, August 15th will be issued a $0.30 dividend. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.27. This represents a $1.20 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date is Wednesday, August 14th. U.S. Physical Therapy’s payout ratio is currently 45.28%.

Hedge funds and other institutional investors have recently made changes to their positions in the business. TCG Advisors LP bought a new stake in U.S. Physical Therapy in the 1st quarter valued at $25,000. NumerixS Investment Technologies Inc bought a new stake in U.S. Physical Therapy in the 2nd quarter valued at $61,000. Ladenburg Thalmann Financial Services Inc. increased its holdings in U.S. Physical Therapy by 74.0% in the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 548 shares of the company’s stock valued at $67,000 after acquiring an additional 233 shares during the last quarter. Quadrant Capital Group LLC increased its holdings in shares of U.S. Physical Therapy by 1,729.4% in the 1st quarter. Quadrant Capital Group LLC now owns 622 shares of the company’s stock worth $63,000 after buying an additional 588 shares during the last quarter. Finally, Tower Research Capital LLC TRC bought a new stake in shares of U.S. Physical Therapy in the 2nd quarter worth about $91,000. Institutional investors own 99.58% of the company’s stock.

USPH has been the topic of a number of research reports. Zacks Investment Research downgraded shares of U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Wednesday. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, May 3rd. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $113.54.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Story: Convertible Shares

Insider Buying and Selling by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Sirius Minerals PLC  Insider Purchases £10,000 in Stock
Sirius Minerals PLC Insider Purchases £10,000 in Stock
Insider Buying: City Merchants High Yield Trust Plc  Insider Purchases 5,000 Shares of Stock
Insider Buying: City Merchants High Yield Trust Plc Insider Purchases 5,000 Shares of Stock
City of London Investment Group PLC  Insider Purchases £4,956.77 in Stock
City of London Investment Group PLC Insider Purchases £4,956.77 in Stock
Quixant PLC  Insider Jon Jayal Buys 2,500 Shares
Quixant PLC Insider Jon Jayal Buys 2,500 Shares
Coca Cola HBC AG  Insider Purchases £4,071.76 in Stock
Coca Cola HBC AG Insider Purchases £4,071.76 in Stock
Anglo American plc  Insider Tony O’Neill Buys 8 Shares
Anglo American plc Insider Tony O’Neill Buys 8 Shares


© 2006-2019 Ticker Report